As we are planning to start a clinical trial on another Ebola vaccine, we tend to have a meeting with our CAB members to discuss on the other stakeholders we will involve and how to go about it considering positive or negative attitude people may have regarding clinical trials. We conducted survey on our trial participants and their response geared towards working with other stakeholders. We are doing this because the trial participants will be different from those who took part in the on going trial so we need to involve different stakeholders.
footer
The views expressed herein do not necessarily reflect the official policies of the City and County of San Francisco; nor does mention of the San Francisco Department of Public Health imply its endorsement. Any questions, comments, or suggestions pertaining to this site may be directed to the site administrator by filling out this form.
© Copyright 2024, Department of Public Health, City and County of San Francisco.
